Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 1092.3
(4.74%)
INR 1092.3
(4.74%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.41 Billion INR | 4.28% |
| 2022 | 1.36 Billion INR | 10.03% |
| 2021 | 1.23 Billion INR | 13.65% |
| 2020 | 1.08 Billion INR | -8.43% |
| 2019 | 1.18 Billion INR | -3.06% |
| 2018 | 1.22 Billion INR | 6.95% |
| 2017 | 1.14 Billion INR | 11.0% |
| 2016 | 1.03 Billion INR | 10.39% |
| 2015 | 935.85 Million INR | 9.83% |
| 2014 | 852.1 Million INR | 11.79% |
| 2013 | 762.24 Million INR | 9.92% |
| 2012 | 693.42 Million INR | 15.92% |
| 2011 | 598.18 Million INR | 5.1% |
| 2010 | 569.15 Million INR | 9.64% |
| 2009 | 519.1 Million INR | 20.06% |
| 2008 | 432.38 Million INR | 7.72% |
| 2007 | 401.4 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 325.35 Million INR | -16.24% |
| 2023 Q3 | 356.59 Million INR | -6.87% |
| 2023 FY | 1.41 Billion INR | 4.28% |
| 2023 Q1 | 291.75 Million INR | -15.66% |
| 2023 Q2 | 382.89 Million INR | 31.24% |
| 2023 Q4 | 388.42 Million INR | 8.92% |
| 2022 Q4 | 345.9 Million INR | 0.07% |
| 2022 Q1 | 311.31 Million INR | 11.02% |
| 2022 Q3 | 345.65 Million INR | -3.59% |
| 2022 FY | 1.36 Billion INR | 10.03% |
| 2022 Q2 | 358.52 Million INR | 15.16% |
| 2021 FY | 1.23 Billion INR | 13.65% |
| 2021 Q1 | 271.79 Million INR | -8.05% |
| 2021 Q2 | 355.08 Million INR | 30.64% |
| 2021 Q3 | 330.02 Million INR | -7.06% |
| 2021 Q4 | 280.41 Million INR | -15.03% |
| 2020 FY | 1.08 Billion INR | -8.43% |
| 2020 Q1 | 174.31 Million INR | -42.43% |
| 2020 Q2 | 304.84 Million INR | 74.89% |
| 2020 Q3 | 318.18 Million INR | 4.38% |
| 2020 Q4 | 295.59 Million INR | -7.1% |
| 2019 Q1 | 208.37 Million INR | -40.68% |
| 2019 Q4 | 302.77 Million INR | -9.87% |
| 2019 Q2 | 341.81 Million INR | 64.04% |
| 2019 Q3 | 335.94 Million INR | -1.72% |
| 2019 FY | 1.18 Billion INR | -3.06% |
| 2018 Q2 | 319.84 Million INR | 37.52% |
| 2018 FY | 1.22 Billion INR | 6.95% |
| 2018 Q4 | 351.25 Million INR | 8.83% |
| 2018 Q1 | 232.58 Million INR | -22.62% |
| 2018 Q3 | 322.75 Million INR | 0.91% |
| 2017 Q3 | 308.74 Million INR | -15.98% |
| 2017 Q4 | 300.58 Million INR | -2.64% |
| 2017 Q2 | 367.47 Million INR | 116.24% |
| 2017 Q1 | 169.94 Million INR | -37.98% |
| 2017 FY | 1.14 Billion INR | 11.0% |
| 2016 Q1 | 223.04 Million INR | 1.47% |
| 2016 Q4 | 274 Million INR | 10.01% |
| 2016 Q3 | 249.06 Million INR | -13.2% |
| 2016 Q2 | 286.94 Million INR | 28.65% |
| 2016 FY | 1.03 Billion INR | 10.39% |
| 2015 Q4 | 219.81 Million INR | -9.18% |
| 2015 FY | 935.85 Million INR | 9.83% |
| 2015 Q1 | 222.2 Million INR | -0.62% |
| 2015 Q2 | 251.78 Million INR | 13.31% |
| 2015 Q3 | 242.04 Million INR | -3.87% |
| 2014 Q1 | 192.26 Million INR | -3.55% |
| 2014 FY | 852.1 Million INR | 11.79% |
| 2014 Q3 | 213.82 Million INR | -3.87% |
| 2014 Q4 | 223.58 Million INR | 4.56% |
| 2014 Q2 | 222.43 Million INR | 15.69% |
| 2013 Q4 | 199.35 Million INR | 2.32% |
| 2013 FY | 762.24 Million INR | 9.92% |
| 2013 Q3 | 194.83 Million INR | -1.38% |
| 2013 Q2 | 197.56 Million INR | 15.88% |
| 2013 Q1 | 170.49 Million INR | -1.24% |
| 2012 Q2 | 196.62 Million INR | 32.96% |
| 2012 Q1 | 147.88 Million INR | -6.15% |
| 2012 FY | 693.42 Million INR | 15.92% |
| 2012 Q4 | 172.64 Million INR | -2.06% |
| 2012 Q3 | 176.28 Million INR | -10.35% |
| 2011 Q3 | 143.96 Million INR | 0.0% |
| 2011 Q4 | 157.56 Million INR | 9.45% |
| 2011 FY | 598.18 Million INR | 5.1% |
| 2010 FY | 569.15 Million INR | 9.64% |
| 2009 FY | 519.1 Million INR | 20.06% |
| 2008 FY | 432.38 Million INR | 7.72% |
| 2007 FY | 401.4 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 362.75 Million INR | -291.359% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 16.403% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -834.753% |
| MedPlus Health Services Limited | 56.24 Billion INR | 97.476% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 2.836% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 29.749% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | -65.402% |
| Beryl Drugs Limited | 271.24 Million INR | -423.385% |
| Cian Healthcare Limited | 616.95 Million INR | -130.108% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -7623.126% |
| Concord Drugs Limited | 449.24 Million INR | -216.011% |
| Deccan Health Care Limited | 597.28 Million INR | -137.685% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -195.92% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -13434.108% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | -35.365% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 53.783% |
| Makers Laboratories Limited | 1.03 Billion INR | -36.818% |
| Medi-Caps Limited | 265.63 Million INR | -434.442% |
| Panchsheel Organics Limited | 1.05 Billion INR | -34.925% |
| Parmax Pharma Limited | 154.24 Million INR | -820.405% |
| Parnax Lab Limited | 1.88 Billion INR | 24.77% |
| Patidar Buildcon Limited | 2.3 Million INR | -61410.615% |
| Phaarmasia Limited | 305.93 Million INR | -364.044% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | -13.201% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -164.433% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -126882.558% |
| Smruthi Organics Limited | 1.27 Billion INR | -11.221% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -420.085% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 69.374% |
| Trident Lifeline Limited | 446.28 Million INR | -218.107% |
| Transchem Limited | 4.09 Million INR | -34525.984% |
| Trinity League India Limited | 2.95 Million INR | -48024.237% |
| Tyche Industries Limited | 696.83 Million INR | -103.73% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -1279.95% |
| Vivanza Biosciences Limited | 278.89 Million INR | -409.038% |
| PRAVEG LIMITED | 915.96 Million INR | -54.991% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 89.531% |
| Sunil Healthcare Limited | 901.91 Million INR | -57.405% |
| Syschem (India) Limited | 2.33 Billion INR | 39.209% |
| Zenith Healthcare Limited | 144.71 Million INR | -880.994% |
| Zenlabs Ethica Limited | 585.63 Million INR | -142.416% |
| Mercury Laboratories Limited | 755.59 Million INR | -87.888% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -254.713% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -283.503% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -218.246% |
| Roopa Industries Limited | 715.53 Million INR | -98.406% |
| PANJON LTD. | 125.52 Million INR | -1031.018% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -839.423% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 78.058% |
| Crestchem Limited | 212.56 Million INR | -567.883% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -25470.335% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -111.006% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 59.223% |
| Trimurthi Limited | 42.23 Million INR | -3261.108% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -90.373% |
| Norris Medicines Limited | 56.35 Million INR | -2419.096% |
| Veerhealth Care Limited | 142.13 Million INR | -898.822% |
| Lactose (India) Limited | 1.13 Billion INR | -24.653% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -258.121% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 18.564% |
| Gennex Laboratories Limited | 867.14 Million INR | -63.717% |
| Denis Chem Lab Limited | 1.67 Billion INR | 15.407% |
| Colinz Laboratories Limited | 70.29 Million INR | -1919.553% |
| Godavari Drugs Limited | 1.56 Billion INR | 9.409% |
| Zenotech Laboratories Limited | 368.08 Million INR | -285.685% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | -12.765% |
| Bharat Parenterals Limited | 2.59 Billion INR | 45.273% |
| Coral Laboratories Limited | 836.6 Million INR | -69.694% |
| Evoq Remedies Limited | 63.09 Million INR | -2150.222% |
| Kerala Ayurveda Limited | 1.02 Billion INR | -38.726% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 8.656% |
| Auro Laboratories Limited | 526.99 Million INR | -169.388% |